Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF injection versus normal saline for androgenetic alopecia
IRCT20200127046282N8Phase 2Completed
- Sponsor
- Skin and Stem Cell Research Center
- Start
- Apr 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-blind trial of autologous adipose stromal vascular fraction in androgenetic alopecia (AGA) (2 arms), sponsored by Skin and Stem Cell Research Center. Primary endpoints: Amount of hair loss, Side effects and 2 more. Started Apr 2022; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20200127046282N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N8.